Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV

類似資料

• Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
  著者:: Clumeck, N, 等
  出版事項: (2010)
• Comparison of the Precision and Sensitivity of the Antivirogram and PhenoSense HIV Drug Susceptibility Assays
  著者:: Zhang, Jie, 等
  出版事項: (2005)
• Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs
  著者:: Pulido, F, 等
  出版事項: (2010)
• Weak Agreement between Antivirogram and PhenoSense Assays in Predicting Reduced Susceptibility to Antiretroviral Drugs
  著者:: Wang, Kai, 等
  出版事項: (2004)
• Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense(®) Entry assay
  著者:: Gartland, Margaret, 等
  出版事項: (2020)